Answers are grounded in this paper and cite their sources.
The optimal surgical approach in curative intended treatment of Siewert type II gastroesophageal junction (GEJ) cancer is a matter of ongoing debate. Esophagectomy or gastrectomy are generally the surgical options to choose from, however several different approaches can be used. The aim of this review is to summarize the available evidence and guide in the decision of how to surgically manage patients with Siewert type II GEJ cancer by comparing transhiatal and transthoracic esophagectomy, proximal and total gastrectomy as well as left thoracoabdominal esophagogastrectomy, gastrectomy and transthoracic esophagectomy. We also assess the extent of lymphadenectomy for different surgical approaches. The reviewed data highlight the lack of high-quality scientific evidence. Based on the current low-grade evidence, esophagectomy with 2-field lymphadenectomy seems to be associated with increased chance of tumor free resection margins, and higher number of resected lymph nodes compared to total gastrectomy, although some studies report higher frequency of postoperative complications. On the other hand, several cohort studies demonstrate similar results comparing esophagectomy, gastrectomy, and left thoracoabdominal esophagogastrectomy. All three techniques are reasonable surgical options for junctional type II cancers and until better evidence is available, the optimal surgical approach should be individually tailored to the patient. The results of the recently started randomized controlled CARDIA trial will add important knowledge, and hopefully support clinicians in the choice between esophagectomy and gastrectomy.
No takes yet. Share an insight, caveat, or question.
Saliba et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: